1. Home
  2. SLN vs HRTG Comparison

SLN vs HRTG Comparison

Compare SLN & HRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLN
  • HRTG
  • Stock Information
  • Founded
  • SLN 1994
  • HRTG 2012
  • Country
  • SLN United Kingdom
  • HRTG United States
  • Employees
  • SLN N/A
  • HRTG N/A
  • Industry
  • SLN Biotechnology: Pharmaceutical Preparations
  • HRTG Property-Casualty Insurers
  • Sector
  • SLN Health Care
  • HRTG Finance
  • Exchange
  • SLN Nasdaq
  • HRTG Nasdaq
  • Market Cap
  • SLN 223.4M
  • HRTG 341.5M
  • IPO Year
  • SLN N/A
  • HRTG 2014
  • Fundamental
  • Price
  • SLN $4.23
  • HRTG $11.88
  • Analyst Decision
  • SLN Buy
  • HRTG Buy
  • Analyst Count
  • SLN 5
  • HRTG 3
  • Target Price
  • SLN $40.80
  • HRTG $12.50
  • AVG Volume (30 Days)
  • SLN 282.3K
  • HRTG 144.6K
  • Earning Date
  • SLN 02-27-2025
  • HRTG 03-11-2025
  • Dividend Yield
  • SLN N/A
  • HRTG N/A
  • EPS Growth
  • SLN N/A
  • HRTG 135.16
  • EPS
  • SLN N/A
  • HRTG 2.43
  • Revenue
  • SLN $43,258,000.00
  • HRTG $793,687,000.00
  • Revenue This Year
  • SLN N/A
  • HRTG N/A
  • Revenue Next Year
  • SLN N/A
  • HRTG $8.54
  • P/E Ratio
  • SLN N/A
  • HRTG $4.89
  • Revenue Growth
  • SLN 36.71
  • HRTG 9.76
  • 52 Week Low
  • SLN $4.06
  • HRTG $6.14
  • 52 Week High
  • SLN $27.72
  • HRTG $16.90
  • Technical
  • Relative Strength Index (RSI)
  • SLN 41.17
  • HRTG 54.29
  • Support Level
  • SLN $4.10
  • HRTG $11.10
  • Resistance Level
  • SLN $5.23
  • HRTG $12.12
  • Average True Range (ATR)
  • SLN 0.40
  • HRTG 0.49
  • MACD
  • SLN 0.06
  • HRTG -0.01
  • Stochastic Oscillator
  • SLN 33.90
  • HRTG 79.66

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid. its pipeline products are; SLN360 therapy designed to temporarily block a specific gene's message that would otherwise trigger an unwanted effect. By silencing the LPA gene, the levels of Lp(a) are lowered, which in turn is expected to lower the risks of heart diseases, heart attacks, and strokes, and SLN124 therapy aims to temporarily silence TMPRSS6, a gene that prevents the liver from producing a particular hormone that controls iron levels in the body hepcidin. As hepcidin increases, iron levels in the blood are expected to decrease, which may increase the production of healthy red blood cells, thereby reducing anemia.

About HRTG Heritage Insurance Holdings Inc.

Heritage Insurance Holdings Inc is a regional property and casualty insurance company that offers a variety of personal and commercial insurance products. Through its subsidiaries, Heritage Property & Casualty Insurance, Narragansett Bay Insurance, and Zephyr Insurance, the company issues personal residential property insurance in various states in the United States. It also offers commercial residential insurance predominantly for its Florida properties. Heritage Insurance manages insurance underwriting, customer services, actuarial analysis, distribution, and claims processing internally.

Share on Social Networks: